News

Amyotrophic lateral sclerosis (ALS)—known as Lou Gehrig's Disease, based on the iconic 1930s New York Yankee baseball ...
ALS patient Bradford Smith became the third patient to test Neuralink — and the first one to do so who had lost the ability ...
The first nonverbal Neuralink patient to receive the chip implant is offering a glimpse into how he uses the technology – editing and narrating a YouTube video using signals from his brain.
The global amyotrophic lateral sclerosis market is on an upward trajectory, demonstrating significant potential for growth and innovation. According to the latest insights from Future Market Insights ...
Reduced levels of a critical protein are linked to devastating brain diseases like Alzheimer's, frontotemporal dementia, and amyotrophic lateral sclerosis (ALS). Surprisingly, the protein shortage ...
Actor Eric Dane recently announced that he has been diagnosed with amyotrophic lateral sclerosis (ALS), a degenerative and incurable disease ...
ALS groups ask lawmakers to preserve federal funding for the National ALS Registry, saying a draft budget memo proposes ...
A former tech executive who lost her husband to amyotrophic lateral sclerosis, ALS, hopes her app will help people with the ...
Brad Smith is the third person in the world to get a brain chip implant with Elon Musk's Neuralink, and the first nonverbal ALS patient to do so.
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty speaking ...